US 12,406,293 B2
Systems and methods for generating personalized skincare formulations based on biomarker analysis
Ji Lee, New York, NY (US); Guive Balooch, New York, NY (US); Fred Orsita, New York, NY (US); Edouard Messager, Paris (FR); Aude Foucher, Aulnay-sous-bois (FR); and Nukhet Cavusoglu, Paris (FR)
Assigned to L'Oreal, Paris (FR)
Filed by L'Oreal, Paris (FR)
Filed on Nov. 14, 2022, as Appl. No. 18/055,191.
Application 18/055,191 is a continuation of application No. 16/528,196, filed on Jul. 31, 2019, granted, now 11,501,356.
Prior Publication US 2023/0206300 A1, Jun. 29, 2023
Int. Cl. G06Q 30/0601 (2023.01); G01N 33/68 (2006.01); G05B 19/414 (2006.01); G16B 50/00 (2019.01)
CPC G06Q 30/0631 (2013.01) [G01N 33/6881 (2013.01); G05B 19/414 (2013.01); G06Q 30/0621 (2013.01); G16B 50/00 (2019.02); G05B 2219/32287 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A non-transitory computer-readable medium having computer-executable instructions stored thereon that, in response to execution by one or more processors of one or more computing devices of a system, cause the system to perform actions for creating custom skincare products, the actions comprising:
receiving, by a skin diagnosis computing device of the system, protein biomarker concentration information from an immunoassay analyzer device configured to determine protein concentrations from a sample provided by a subject by measuring fluorescence;
determining, by the skin diagnosis computing device, at least one skincare product ingredient based on the protein biomarker concentration information; and
transmitting, by the skin diagnosis computing device, the determined at least one skincare product ingredient to a skincare product formulation device of the system for creation of a custom skincare product.